SCHEMBL5686178

SCHEMBL5686178

CN1CCN(CCCOc2ccc(Nc3ncc(C(N)=O)cn3)cc2F)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 2/20 0.52
KDR P35968 4/20 0.48
LCK P06239 2/20 0.48
SRC P12931 2/20 0.48
MAPK14 Q16539 1/20 0.48
TLR7 Q9NYK1 1/20 0.46
BTK Q06187 4/20 0.45
JAK3 P52333 2/20 0.45
AXL P30530 4/20 0.45
INSR P06213 1/20 0.45
EGFR P00533 5/20 0.43
MET P08581 3/20 0.43
ERBB2 P04626 1/20 0.43
FLT3 P36888 2/20 0.42
PLK1 P53350 1/20 0.42
PLK3 Q9H4B4 1/20 0.42
PLK2 Q9NYY3 1/20 0.42
PDGFRB P09619 1/20 0.42
KIT P10721 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4507920 0.95 AXL (0.49) CSF1RKDRLCKSRCMAPK14
SCHEMBL4495452 0.93 EGFR (0.48) CSF1RKDRLCKSRCMAPK14
SCHEMBL4494805 0.92 AXL (0.52) CSF1RKDRLCKSRCMAPK14
SCHEMBL4495092 0.91 AXL (0.51) CSF1RKDRLCKSRCMAPK14
SCHEMBL4494947 0.90 INSR (0.54) KDRBTKJAK3AXLINSR
SCHEMBL5689296 0.89 AXL (0.49) CSF1RKDRLCKSRCBTK
SCHEMBL4489929 0.87 AXL (0.57) CSF1RKDRLCKBTKJAK3
SCHEMBL4499318 0.86 AXL (0.56) CSF1RKDRLCKBTKAXL
SCHEMBL5689284 0.86 AXL (0.47) CSF1RKDRLCKSRCBTK
SCHEMBL4503003 0.86 MET (0.45) CSF1RKDRLCKSRCMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed